THOUGHTS, INSIGHTS, AND PERSPECTIVES.

blog-hero

Hope’s d-Nav Journey

Hope has been using d-Nav consistently for nearly a year. She credits a new-found therapy adherence to d-Nav’s ease of use and provider support.

Autonomous Insulin Dose Adjustments: A Game-Changer in Type 2 Diabetes Care

Diabetes affects more than 37 million people in the U.S. and increases their risk of early death by 60%.1 Numerous clinical studies show that the maintenance of glycated hemoglobin (HbA1c) at about 7% prevents complications, slows the disease progression, and prevents premature death. Despite advances in pharmacotherapy, most patients with long-standing type 2 diabetes progress…

What HbA1c level do I need to aim for?

If you have diabetes, you have most likely heard that you should aim for an HbA1c measure of 7 percent or lower. But what does this really mean? HbA1c is a measure of average glucose over a period of about 2-3 months. It essentially evaluates how much glucose binds to your hemoglobin. Since red blood…

Insulin’s Next Century: Technology’s role in unlocking the power of insulin

One hundred years ago a group of Canadian scientists and physicians discovered insulin. Frederick Banting, J.R. Macleod, Charles Best and James Collip’s historic finding meant the difference between life and death for people with diabetes.  Nearly a century later, Hygieia co-founder Dr. Israel Hodish published a paper1 in Clinical Diabetes and Endocrinology asking the question,…

Diabetes discriminates: Why one’s ethnicity can impact the likelihood of developing type 2 diabetes and suffering from its complications

Type 2 diabetes affects about 10% of the general population in the United States. Yet, it occurs in nearly 15% of the Native-American population, nearly 12% of the non-Hispanic black population, and nearly 13% of the Hispanic population, according to the American Diabetes Association. Why does type 2 diabetes impact some ethnicities and races more…

Insulin Therapy: The How and Why of Dose Changes

Most patients who use insulin therapy use it for type 2 diabetes. Type 2 diabetes is a progressive condition of insulin deficiency, which means that over time the body secretes less and less insulin. During the second decade of the disease, most patients require insulin injections because they become overtly insulin deficient and no longer…

Diabetes and heart disease: How to manage the risk

Although diabetes is a condition of the endocrine system, it also can affect many other systems in the body. For example, there is a strong link between diabetes and cardiovascular disease.  In fact, cardiovascular disease is the most prevalent cause of death (mortality) and complications (morbidity) in diabetic populations. Cardiovascular death rates in the United…

What We Know About Type 2 Diabetes and the Covid-19 Vaccines

As the coronavirus continues to impact lives around the world, the promise of COVID-19 vaccines brings new hope. In the United States, two vaccines are already in use and more are in development.  If you have type 2 diabetes, you might be wondering if you should get the Covid-19 vaccine when it becomes available. The…

Artificial Intelligence: Just what the doctor ordered

Medicine is the next industry where AI will replicate human decision making Just as the 2008 recession ushered in an era of unbridled innovation in financial tech, the effects of the COVID-19 pandemic are similarly accelerating a radical shift in medicine. In the last year, as COVID-19 overwhelmed hospitals and physicians struggled to deliver care…

Insulin Therapy and the Weight Paradox

Most patients with adult-onset diabetes or type 2 diabetes will require insulin therapy at some point. Typically, it happens toward the second decade of the disease. In many cases, patients gain weight during the first six to 12 months after they start insulin therapy. On average, people gain about 10 pounds.  Interestingly, insulin therapy does…

Good Diabetes Management Does Not Have to Be Expensive

One of the complaints I receive from patients is that diabetes is just too expensive to manage. Medications cost a lot of money every month despite insurance coverage. It has been found that about one of every four insulin users rations their doses to reduce cost. You may find it surprising, but I believe that…

Poor HbA1c Control is a Medical Emergency

As an endocrinologist, I see many patients with long-standing type 2 diabetes. The typical first-time patient in my practice is a man or a woman between age 40 – 60, who has had type 2 diabetes for more than 10 years, is being treated with four different medications (some of which belong to new classes…

Six Years Later, Our Vision is Still the Same

Northern Ireland, where Hygieia has a wholly owned subsidiary of which Bashan is managing director. His topic: inventions – specifically, what inventions must do to travel from concept to popular adoption. He was well qualified to speak on this, having just expanded Hygieia’s d-Nav® insulin management program from a small, independent project to an AI-powered…